↓ Skip to main content

Dove Medical Press

Article Metrics

High burden and unmet patient needs in chronic kidney disease

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, December 2012
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#26 of 130)
  • Above-average Attention Score compared to outputs of the same age (58th percentile)

Mentioned by

4 tweeters


60 Dimensions

Readers on

103 Mendeley
High burden and unmet patient needs in chronic kidney disease
Published in
International Journal of Nephrology and Renovascular Disease, December 2012
DOI 10.2147/ijnrd.s37766
Pubmed ID

Vipan Sood, Braun, Hogue, Lieberman, Copley-Merriman, LeeAnn Braun, Susan Hogue, Bonnie Lieberman, Catherine Copley-Merriman


Chronic kidney disease (CKD) is a complex debilitating condition affecting more than 70 million people worldwide. With the increased prevalence in risk factors such as diabetes, hypertension, and cardiovascular disease in an aging population, CKD prevalence is also expected to increase. Increased awareness and understanding of the overall CKD burden by health care teams (patients, clinicians, and payers) is warranted so that overall care and treatment management may improve. This review of the burden of CKD summarizes available evidence of the clinical, humanistic, and economic burden of CKD and the current unmet need for new treatments and serves as a resource on the overall burden. Across countries, CKD prevalence varies considerably and is dependent upon patient characteristics. The prevalence of risk factors including diabetes, hypertension, cardiovascular disease, and congestive heart failure is noticeably higher in patients with lower estimated glomerular filtration rates (eGFRs) and results in highly complex CKD patient populations. As CKD severity worsens, there is a subsequent decline in patient health-related quality of life and an increased use of health care resources as well as burgeoning costs. With current treatment, nearly half of patients progress to unfavorable renal and cardiovascular outcomes. Although curative treatment that will arrest kidney deterioration is desired, innovative agents under investigation for CKD to slow kidney deterioration, such as atrasentan, bardoxolone methyl, and spherical carbon adsorbent, may offer patients healthier and more productive lives.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
South Africa 1 <1%
Unknown 101 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 19%
Researcher 17 17%
Other 12 12%
Student > Bachelor 11 11%
Student > Ph. D. Student 10 10%
Other 14 14%
Unknown 19 18%
Readers by discipline Count As %
Medicine and Dentistry 32 31%
Nursing and Health Professions 11 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 10%
Agricultural and Biological Sciences 7 7%
Biochemistry, Genetics and Molecular Biology 6 6%
Other 16 16%
Unknown 21 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2017.
All research outputs
of 11,374,668 outputs
Outputs from International Journal of Nephrology and Renovascular Disease
of 130 outputs
Outputs of similar age
of 309,834 outputs
Outputs of similar age from International Journal of Nephrology and Renovascular Disease
of 4 outputs
Altmetric has tracked 11,374,668 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 130 research outputs from this source. They receive a mean Attention Score of 1.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them